













Autonomous functioning thyroid nodule  
— a rare paediatric diagnosis
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Autonomous functioning thyroid nodules (AFTN) may 
be defined as nodules in which follicular cells have 
a TSH (and antibody)-independent function [1–3]. 
These are not uncommon in adults but are exceptionally 
rare in patients under 18 years of age [3], with a higher 
prevalence in females [1, 2]. 
Patients with AFTN may either exhibit symptoms 
of hyperthyroidism or be clinically euthyroid [1, 3–5]. 
Symptomatic hyperthyroidism and/or the detection of 
a cervical mass are, most often, the presenting features [3]. 
Autonomous functioning thyroid nodules are diag-
nosed by a suppressed TSH and increased, nodule-spe-
cific uptake on thyroid scintigraphy [2, 3, 5], and surgical 
resection is, according to current guidelines, the recom-
mended approach for most AFTN in this age group [3, 5].
A 17-year-old female, obese (BMI 36.7 kg/m2, P > 97), 
with no other relevant priors, sought medical advice in 
our Emergency Department (ED), for a progressively 
growing cervical mass, noticed in the last month, that 
caused intermittent dysphagia. At physical examina-
tion, an anterior mass was visible and palpable, 4 cm 
in its largest diameter, soft, elastic, and painless to 
palpation (Fig. 1). An ED ultrasound described a mixed 
nature thyroid nodule in the transition of the left lobule 
to the isthmus, measuring 3.7 × 1.5 cm. No irregular 
margins or calcifications were described and no other 
surrounding masses or adenomegalies were found. The 
patient was discharged after Paediatric Oncology and 
Endocrinology consultations were scheduled.
Ten days later, on her first outpatient evaluation, 
thyroid function was accessed, revealing normal fT4 
and TSH levels (10.43 pmol/L and 0.52 mIU/mL, re-
spectively) and negative thyroid antibodies (TPOAb, 
TRAb, and TgAb), and a fine needle aspiration biopsy 
was performed, identifying the lesion as a benign fol-
licular nodule. After discussion in a Paediatric Oncology 
Group Consultation (POGC), an expectant manage-
ment strategy was adopted.
Four months later, the patient maintained intermit-
tent dysphagia but also described occasional breath-
ing discomfort and feeling “constantly tired”. A new 
ultrasound (Fig. 2) described an enlargement of the 
lesion (4 × 3.8 × 2.2 cm) which retained its radiological 
characteristics. On a new POGC, surgical excision of the 
mass was decided and scheduled, based on the patient’s 
symptoms and the nodule’s apparent continuous growth.
Thyroid function was, at the time, reassessed, 
revealing normal fT4 levels but clearly suppressed 
Figure 1. Macroscopic aspect of the mass on presentation
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The lesion’s size and apparent continuous growth led to 
a surgical approach, which, as previously mentioned, is 
the recommended approach for most paediatric AFTN. 
Although rare, AFTN should be part of the differ-
ential diagnosis for thyroid nodules in the paediatric 
population, even if the patient is clinically euthyroid 
and initial thyroid function assessments are normal. 
Thyroid function should be routinely assessed in pa-
tients with thyroid nodules, and, if suppressed TSH 
levels are found, a thyroid scintigraphy should be 
performed. 
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TSH and elevated thyroglobulin levels (respectively, 
12.10 pmol/L, 0.09 mIU/mL and 386 µg/L). At this point 
suspicions arose of a possible AFTN, and a subsequent 
thyroid scintigraphy further confirmed that hypothesis, 
describing a distinctly increased uptake of I131 by the 
mass and decreased uptake by the remaining thyroid 
tissue (Fig. 3). The patient was started on Atenolol and 
Metibasol with subsequent improvement of thyroid 
function levels (fT4 10.04 pmol/L and 11.07 pmol/L; TSH 
0.68 mIU/mL and 0.93 mIU/mL, at 1 and 4 months of 
treatment, respectively).
A few months later, the patient underwent a left 
hemithyroidectomy and isthmectomy without any 
intercurrences (Fig. 4). Surgical pathology of the lesion 
described an encapsulated nodule compatible with 
a follicular adenoma, morphologically consistent with 
previous suspicions of an AFTN.
After the surgery, all pharmacological treatment was 
suspended, and the patient currently remains euthy-
roid and completely asymptomatic (Fig. 5).
We describe the case of a paediatric patient who sought 
medical attention after noticing a growing anterior 
cervical mass. Although initial thyroid function stud-
ies did not show any imbalances, a clearly suppressed 
TSH level, which suggested TSH-independent thyroid 
hormone production, was documented on follow-up. 
This led to the suspicion of an AFTN, which was subse-
quently confirmed in an unambiguous I131 scintigraphy. 
Figure 2. Ultrasound image of the lesion 
Figure 3. I131 Scintigraphy image. A specific hypercaptation region 
can be noticed while minimal radionuclide uptake is present in the 
extranodular area
Figure 5. The patient’s anterior cervical area, 40 days after surgery 
Figure 4. Photographs of the nodule in situ and after surgical 
resection
